Get all your news in one place.
100's of premium titles.
One app.
Start reading
AAP
AAP
Derek Rose

ASX soon to get its first erectile dysfunction company

LTR Pharma is preparing to launch its SPONTAN nasal spray which treats erectile dysfunction. (HANDOUT/H^CK DIGITAL)

This is one company that probably won't get a limp reception from the market.

Brisbane-based LTR Pharma on Friday opened its $7 million initial public offering to fund its planned launch of a fast-acting treatment for erectile dysfunction. 

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.